Pharmacological properties of dehydroascorbic acid and ascorbic acid. Effects on the central and peripheral nervous systems in experimental animals.
D000109:Acetylcholine / Q000494:pharmacology; D000311:Adrenal Glands / Q000187:drug effects; D000315:Adrenalectomy; D000818:Animals; D001205:Ascorbic Acid / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D001949:Bretylium Compounds / Q000494:pharmacology; D002247:Carbon Isotopes; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D002845:Chromatography; D003042:Cocaine / Q000494:pharmacology; D002818:Cordotomy; D004298:Dopamine / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D009469:Neuromuscular Junction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D010525:Peripheral Nerves / Q000187:drug effects*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D012472:Salivation / Q000187:drug effects; D013757:Tetraethylammonium Compounds / Q000494:pharmacology
D001949:Bretylium Compounds; D002247:Carbon Isotopes; D006584:Hexamethonium Compounds; D013757:Tetraethylammonium Compounds; D010643:Phenoxybenzamine; D012110:Reserpine; D011433:Propranolol; D003042:Cocaine; D000109:Acetylcholine; D007099:Imipramine; D001205:Ascorbic Acid; D004878:Ergotamine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine; D006145:Guanethidine